Introduction {#s1}
============

Oral squamous cell carcinoma (OSCC) is the sixth most common cancer worldwide. It is the cause of over 400,000 cancer related deaths each year, with 80% of deaths occurring in developing countries^\[[@b1]\]^. The incidence rate of OSCC is increasing, especially in younger people^\[[@b2]\]^. In addition, OSCC accounts for over 40% of head and neck squamous cell carcinoma (HNSCC). According to the American Cancer Society, while the overall cancer cases have increased by approximately 8% in the last five years, the number of new cases of OSCC has increased by approximately 21%^\[[@b3]\]^. OSCC has a very poor prognosis due to its invasive nature, and despite advances in treatment and diagnostics, the five-year survival rate is below 50% and has not improved in the last three decades^\[[@b2]\]^.

In common with other cancers, the development and progression of OSCC is a multistep process with the accumulation of genetic and epigenetic changes^\[[@b4]\]^. It is generally accepted that many of cancer-associated gene changes originate with the gain, loss, or mutation of genetic information^\[[@b5]\]^. Therefore, studying these genetic changes improves understanding of the molecular basis of cancer in order to deliver potential diagnostic or outcome markers, and therapeutic targets for cancer patients.

Recent studies have indicated that changes of mRNA expression levels in OSCC is associated with tumor development, maintenance, and progression^\[[@b6]-[@b7]\]^. As a consequence, inducing or silencing mRNA expression of these oncogenes or anti-oncogenes has been used as a method to control and treat neoplasms^\[[@b8]-[@b9]\]^. In addition, mRNAs could potentially be used as biomarkers of OSCC or other oral cancers^\[[@b10]-[@b11]\]^.

In large-scale clinical studies, genome-wide gene expression profiling can advance the discovery of cancer biomarkers and therapeutic targets. The human transcriptome is highly complex; the human genome encodes 20,000--25,000 genes. In contrast, because each gene can produce multiple transcripts and, thereby, multiple proteins, the proteome is many times larger and diverse in its functions^\[[@b12]\]^. Therefore, efficient sequencing technologies are urgently required.

High-throughput RNA sequencing (RNA-Seq) and the rapid development of new technologies is providing unprecedented opportunities for interrogating the human transcriptome^\[[@b13]\]^. This has led to next generation sequencing (NGS) applications, such as Illumina/Solexa, Applied Biosystems/SOLiD, and Roche/454 FLX^\[[@b14]\]^. Compared to traditional techniques, NGS offers greatly improved dynamic ranges and specificity for transcriptome analyses, while sample throughput is continuously increasing and costs are being reduced^\[[@b15]\]^.

Although there have been published reports on the successful construction of genome-wide mRNA expression profiles in other types of cancer, highlighting the power and capabilities of high-throughput sequencing techniques, there have been relatively few relating to OSCC^\[[@b16]-[@b17]\]^. In this study, we exploited high-throughput RNA-Seq technology to construct comprehensive mRNA expression profiles of OSCC and matched paraneoplastic normal tissues. We used the information to explore and predict the molecular functions and biological pathways of the differentially expressed mRNAs. Our results have provided a basis for identifying further molecular markers for the diagnosis and treatment of OSCC.

Materials and methods {#s2}
=====================

Tissue samples {#s2a}
--------------

All the samples used in this study were selected from OSCC patients treated at Affiliated Stomatological Hospital of Nanjing Medical University between November 2011 and February 2012. Written informed consent was obtained from all patients and the study protocol was approved by the Institutional Review Board of Affiliated Stomatological Hospital of Nanjing Medical University. Ten pairs of OSCC tissue and matched paraneoplastic normal tissue specimens, which had been identified by pathologists, were collected and fresh-frozen immediately after surgery, and stored at −80°C. The proportion of cancer cells in a tissue section was greater than 80%. None of the patients had received preoperative chemotherapy, radiotherapy, or any other anticancer treatment prior to surgery. Clinical characteristics of the patients are given in [***Table 1***](#t01){ref-type="table"}.

###### Clinicopathologic data of 10 patients included in the study

  Variables                  *n*
  ---------------------- ------------
  Male sex, *n*(%)          6(60)
  Age, years, *n*(%)     
   ≤ 50                     2(20)
   51--60                   3(30)
   61--70                   3(30)
   ≥ 71                     2(20)
  Location, *n*(%)       
   Bucca mucosa             4(40)
   Tongue                   4(40)
   Gingiva                  2(20)
  Grade                  
   I                        3(30)
   II                       6(60)
   III                      1(10)
  TNM staging, *n*(%)    
   T1                       7(70)
   T2                       3(30)
   N = 0                    4(40)
   N\>0                      6(6)
  Mean size(SD), cm^3^    2.75(1.54)

Illumina Solexa sequencing {#s2b}
--------------------------

Total RNA was isolated from the 10 paired fresh-frozen OSCC tissue and matched paraneoplastic normal tissue specimens using TRIzol® (Invitrogen, Carlsbad, CA, USA) according to the manufacturer\'s protocol. The integrity of the RNA was evaluated using the Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA, US). The mRNA was purified from extracted total RNA using Oligo (dT) magnetic beads adsorption, and converted into double-stranded cDNA by reverse transcription. *Nla*III was used to digest the cDNA and the Illumina adaptor 1 was ligated. *Mme*I was used to digest the CATG site and the Illumina adaptor 2 was ligated to the 3′ end. Primer GX1 and GX2 were used for PCR. The DNA was purified, and sequencing was performed by the Illumina Cluster Station and Genome Analyzer (Illumina Inc., CA, USA) at Beijing Genomics Institute, Shenzhen, according to the manufacturer\'s protocol.

Data processing {#s2c}
---------------

Sequencing-received raw image data were transformed by base calling into sequence data (termed raw data or raw reads). Dirty tags were filtered through data processing steps. Clean tags were obtained by sequence quality assessment; saturation analysis of sequencing, and experimental repeatability analysis. Subsequently, all clean tags were mapped to the reference sequences and only one-bp mismatch was accepted. Clean tags mapped to reference sequences from multiple genes were filtered and the remaining clean tags were designated as unambiguous clean tags. The number of unambiguous clean tags for each gene was calculated and normalized to the number of transcripts per million (TPM) of clean tags^\[[@b18]-[@b19]\]^.

Screening of differentially expressed genes {#s2d}
-------------------------------------------

Differentially expressed genes (DEGs) between OSCC samples and their matched paraneoplastic normal samples were identified by a rigorous algorithm^\[[@b20]\]^. False discovery rate (FDR) was used as a statistical method to determine the threshold *P*-value by multiple testing and analyzed by manipulating the FDR value^\[[@b21]\]^. The levels of mRNA expressions in the paired samples were calculated by log~2~Ratio. For this study, we applied an FDR ≤0.001 and the absolute value of log~2~Ratio ≥ 1 as the threshold to judge the significance of gene expression difference.

Gene Ontology functional enrichment analysis for DEGs {#s2e}
-----------------------------------------------------

For gene expression profiling analysis, Gene Ontology (GO) enrichment analyses of functional significance were performed by hypergeometric testing to map all differentially expressed genes to GO terms (each GO term belongs to a type of ontology in the GO database; <http://www.geneontology.org>). Searches were carried out for significantly enriched GO terms in DEGs, compared to the genome background. The *P*-value was corrected by Bonferroni and a corrected *P*-value of 0.05 was used as the threshold to judge the differential gene expression of significantly enriched GO terms.

Pathway enrichment analysis of DEGs {#s2f}
-----------------------------------

The Kyoto Encyclopedia of Genes and Genomes (KEGG; <http://www.genome.jp/kegg>)^\[[@b22]\]^ was used for pathway enrichment analysis of significance by using the hypergeometric test to map all DEGs and search for pathways significantly enriched in DEGs, compared to the genome background. We defined a *Q*-value of 0.05 as the threshold to judge the differential gene expression of significantly enriched pathways.

Real-time PCR {#s2g}
-------------

We selected one of the most up-regulated mRNAs (*MAGEA11*) and one of the most down-regulated mRNAs (*TCHH*) for confirmation against 15 other paired OSCC tissue and adjacent normal tissue samples. SnRNA U6 was used as the endogenous control. Specific primer sets for *MAGEA11*, *TCHH* and U6 were obtained from Genecopoeia, Guangzhou, China.

Total RNA was extracted from 15 paired snap-frozen OSCC, matched to normal controls using TRIzol reagent (Invitrogen), and transcribed into cDNAs. The reaction mixture contained 10×AMV Reaction Buffer, DTT (200 mmol/L), dNTPs (10 mmol/L), reverse transcriptase (AMV), RNase inhibitor (40 u/*μ*L), primer, nuclease-free water, and total RNA (4 *μ*g). The mixture was incubated for 60 minutes at 42 °C and 10 minutes at 85 °C.

For each mRNA amplification, a total reaction volume of 20 *μ*L containing 2×SYBR Green Real-time PCR master mix, mRNA primers, the cDNA template, and diethyl pyrocarbonate (DEPC)-treated water was used. The PCR procedure was as follows: 95 °C for 5 minutes; 40×15 seconds cycles at 95 °C; 60 °C for 30 seconds; and 72 °C for 30 seconds. To quantify changes in gene expression, relative mRNA expressions were calculated according to the formula; 2^-*ΔΔ*Ct\[[@b19]\]^.

Statistical analysis {#s2h}
--------------------

Data was expressed as mean±SEM. Statistical analysis was performed using SPSS v17.0 software and Student\'s *t*-test was used to analyze the OSCC tissue and adjacent normal tissue samples. *P*\<0.05 was considered statistically significant.

RESULTS {#s3}
=======

Differentially expressed mRNAs {#s3a}
------------------------------

By constructing the mRNA expression profile of OSCC and analyzing the sequence data, we identified 1,120 significantly up-regulated mRNAs and 178 significantly down-regulated mRNAs. These included *MAGEA11* (log~2~Ratio = 10.252665), which was up-regulated \>1,000-fold, and *TCHH* (log~2~Ratio = −10.759888), which was down-regulated \>1,700-fold. The 10 most up-regulated and down-regulated mRNAs are shown in [***Table 2***](#t02){ref-type="table"}.

###### The 10 most up-regulated and down-regulated mRNAs in OSCC

  Up-regulated in OSCC    Down-regulated in OSCC                                         
  ---------------------- ------------------------ ------------- ------------ ----------- -------------
  mRNA                          *P*-value          log~2~Ratio      mRNA      *P*-value   log~2~Ratio
  MAGEA11                        2.96E-13           10.25267        TCHH      4.41E-18     −10.7599
  PHACTR3                        9.44E-11           9.930737       SYTL4      1.57E-08     −9.60733
  COL10A1                        3.99E-10           9.837628       EPHX3      2.26E-07     −9.37721
  PPAPDC1A                       1.68E-09           9.738092       KRT33B     1.23E-05     −8.93958
  EMR1                           3.46E-09           9.686501      CTTNBP2     2.40E-05     −8.85175
  FAM132A                        3.46E-09           9.686501       ESYT3      4.67E-05     −8.75822
  CHRNA1                         3.46E-09           9.686501     NCRNA00162   4.67E-05     −8.75822
  LRRC17                         7.12E-09           9.631177       SYTL5      4.67E-05     −8.75822
  ODZ3                           6.18E-08           9.455327       CACNB4     4.67E-05     −8.75822
  BAALC                          2.61E-07           9.324181       CRTAC1     9.10E-05     −8.66178

GO functional enrichment analysis: cellular components {#s3b}
------------------------------------------------------

Through GO enrichment analysis, we determined that the differentially expressed mRNAs were significantly enriched in the following cellular components: extracellular region; extracellular matrix; proteinaceous extracellular matrix; collagen; cytoplasm; endoplasmic reticulum; macromolecular compounds; fiber collagen ([***Table 3***](#t03){ref-type="table"}).

###### Cellular distribution of the DEGs

                                        Cluster frequency         
  ------------------------------------ ------------------- ------ ----------
  Extracellular region part                    154          13.6   2.54E-15
  Extracellular region                         156          13.8   2.69E-15
  Extracellular matrix                         65           5.7    2.63E-12
  Extracellular matrix part                    20           1.8    1.00E-08
  Proteinaceous extracellular matrix           27           2.4    7.57E-06
  Collagen                                     10           0.9    1.64E-05
  Cytoplasm                                    362          32.0   3.50E-05
  Cytoplasmic part                             360          31.8   4.52E-05
  Endoplasmic reticulum part                   34           3.0    0.00929
  Macromolecular complex                       252          22.2   0.01500
  Fibrillar collagen                            4           0.4    0.02594

DEGs: differentially expressed genes

GO functional enrichment analysis: molecular functions {#s3c}
------------------------------------------------------

The results of GO molecular function analysis showed that the differentially expressed mRNAs were significantly enriched in the following molecular functions: endopeptidase activity; growth factor binding; peptidase activity; protein binding, peptidase activity, acting on *L*-amino acid peptides; oxidoreductase activity; and cytokine activity ([***Table 4***](#t04){ref-type="table"}). Protein binding was found to be the function with the highest level of enrichment with 353 differentially expressed mRNAs.

###### Molecular function of the DEGs

                                                         Cluster frequency         
  ----------------------------------------------------- ------------------- ------ ----------
  Endopeptidase activity                                        60           5.7%   9.09E-07
  Growth factor binding                                         22           2.1    4.19E-05
  Peptidase activity                                            70           6.7    0.00090
  Protein binding                                               354          33.8   0.00130
  Peptidase activity, acting on L-amino acid peptides           69           6.6    0.00131
  Oxidoreductase activity                                       69           6.6    0.02030
  Cytokine activity                                             12           1.1    0.04538

To validate the results of deep sequencing, the differential expression of *MAGEA11* and *TCHH* were verified by real-time PCR against 15 paired OSCC and adjacent normal tissues. The results showed that *MAGEA11* expression was up-regulated in the tumor samples. The mean expression of *MAGEA11* in OSCC tissues (3.0518±1.5700) was significantly higher than in normal tissues (*P*\<0.05; [***Fig. 1A***](#f01){ref-type="fig"}); *TCHH* expression was down-regulated in the tumor samples. The mean expression of *TCHH* in OSCC tissues (0.5388±0.1700) was significantly lower than normal tissues (*P*\<0.05; [***Fig. 1B***](#f01){ref-type="fig"}).

![Expression of MAGEA11 (A) and TCHH (B) in OSCC tissues.\
A: MRNA transcript levels *MAGEA11* and B: *TCHH* in oral squamous cell carcinoma (OSCC) tissues *n*  =  15, \**P* \< 0.05 vs. normal controls.](jbr-29-05-397-g001){#f01}

GO functional enrichment analysis: biological processes {#s3d}
-------------------------------------------------------

GO biological process analysis showed that the differentially expressed mRNAs were significantly enriched in a total of 20 biological processes, including: extracellular structure organization, immune system process, and response to wounding ([***Table 5***](#t05){ref-type="table"}). The processes found to be most involved were the immune response, anatomical structure development, response to organic substance, developmental process, and response to stimulus.

###### Biological process associated with DEGs

                                                              Cluster frequency         
  ---------------------------------------------------------- ------------------- ------ ----------
  Extracellular structure organization                               32           3.0    3.62E-05
  Immune system process                                              119          11.3   0.00012
  Response to wounding                                               42           4.0    0.00036
  Regulation of multicellular organismal development                 60           5.7    0.00240
  Cell motility                                                      72           6.8    0.00266
  Localization of cell                                               72           6.8    0.00266
  Cellular component movement                                        72           6.8    0.00343
  Collagen metabolic process                                         10           0.9    0.00379
  Locomotion                                                         82           7.8    0.00629
  Multicellular organismal macromolecule metabolic process           11           1.0    0.00768
  Extracellular matrix organization                                  14           1.3    0.00979
  Anatomical structure development                                   271          25.6   0.01196
  Regulation of developmental process                                85           8.0    0.01237
  Cell migration                                                     59           5.6    0.01513
  Multicellular organismal metabolic process                         11           1.0    0.01541
  Response to organic substance                                      108          10.2   0.01566
  Tissue development                                                 91           8.6    0.02052
  Developmental process                                              316          29.9   0.03336
  Response to stimulus                                               298          28.2   0.03626
  Signal transmission via phosphorylation event                      68           6.4    0.03752

Pathway enrichment analysis {#s3e}
---------------------------

The differentially expressed genes in the OSCC samples and matched paraneoplastic normal samples were involved in a total of 215 signaling pathways. Of these, 68 signaling pathways were significantly enriched (*Q*-value ≤ 0.05), e.g., extracellular matrix (ECM)-receptor interaction, rheumatoid arthritis, and focal adhesion. [***Table 6***](#t06){ref-type="table"} shows the 10 most significantly enriched pathways.

###### The DEGs with pathway annotation

                                         DEGs with pathway annotation         
  ------------------------------------- ------------------------------ ------ --------------
  ECM-receptor interaction                            37                3.53   6.620198E-05
  Rheumatoid arthritis                                22                2.1    1.021563E-04
  Focal adhesion                                      58                5.53   1.021563E-04
  Antigen processing and presentation                 23                2.19   2.146282E-04
  Type I diabetes mellitus                            14                1.33   1.137989E-03
  Graft-versus-host disease                           14                1.33   5.377383E-03
  Lysosome                                            26                2.48   7.047030E-03
  Amoebiasis                                          30                2.86   8.074916E-03
  Allograft rejection                                 11                1.05   1.000477E-02
  Pathways in cancer                                  56                5.34   1.178707E-02

Discussion {#s4}
==========

By utilizing high-throughput RNA-Seq technology, we have constructed genome-wide mRNA expression profiles in OSCC and detected 1,120 up-regulated mRNAs and 178 down-regulated mRNAs in OSCC tissue, compared with matched paraneoplastic normal tissue. These findings suggest that these aberrantly expressed mRNAs may play roles in OSCC development and progression. The most significantly up-regulated mRNAs was MAGEA11, which has been reported to be oncogenic. Bai *et al.* showed that high expression of MAGEA11 increased the androgen receptor (AR)-dependent cell proliferation and promoted the development of prostate cancer^\[[@b23]\]^. Lian *et al.* reported that MAGEA11 expression was more frequent in breast cancer tissue, compared to tumor-free breast tissue, suggesting that MAGEA11 may be involved in estrogen receptor (ER)-dependent cell proliferation and could act as a potential prognostic factor of poor outcome in breast cancer patients^\[[@b24]\]^. Tsaia *et al.* reported differential expression of MAGEA11 in non-small cell lung cancer (NSCLC) ^\[[@b25]\]^. In contrast, the role of THCC, which was the most significantly down-regulated mRNA detected in our study, is unclear. In common with previous reports on mRNAs in OSCC, similar results were obtained in our study: MMP1 (log~2~Ratio = 1.038711) and MMP3 (log~2~Ratio = 3.488456) have been reported as highly expressed in OSCC, and put forward as robust diagnostic biomarkers^\[[@b26]\]^. PLAU (log~2~Ratio = 1.925736) has been implicated in enhanced cell proliferation and migration and, has been proposed as a prognostic marker of relapse-free survival of OSCC, together with its receptor uPAR^\[[@b27]\]^. Sapkota *et al.* reported that S100A14 (log~2~Ratio =  −1.595579) was progressively down-regulated in vitro during the transition from normal to dysplastic stages of cancer in OSCC progression. In addition, an inverse correlation between mRNA expression levels of MMP1 and MMP9 with S100A14 was found in 19 cases of OSCC^\[[@b28]\]^. Other differentially expressed mRNAs identified in our study have been also been reported in different cancers, including AZGP1 (log~2~Ratio =  8.392317), COL1A1 (log~2~Ratio = 2.460066), SPARC (log~2~Ratio = 1.866150), COL4A1 (log~2~Ratio =  1.487532), ISG15 (log~2~Ratio = 1.434671), RUNX3 (log~2~Ratio = 1.430360), and KRT19 (log~2~Ratio = −2.864896) ^\[[@b29]-[@b31]\]^.

Gene Ontology (GO) is an international standardized gene functional classification system which offers a dynamic-updated vocabulary to comprehensively describe properties of genes and their products in any organism. GO has three ontologies: molecular function, cellular component, and biological process. Every GO term belongs to one of these ontologies^\[[@b32]\]^. Because genes often cooperate with each other to perform their biological functions, pathway analyses facilitate further understanding genes and their roles^\[[@b33]\]^.

In this study, the results of GO functional enrichment analyses indicated that differentially expressed mRNAs in OSCC: were significantly enriched in cellular components, including extracellular region, extracellular matrix, macromolecular complex and cytoplasm; involved molecular functions that included endopeptidase activity, growth factor binding, peptidase activity; and may be involved in biological processes which are closely related to the development and progression of cancer, including immune system process, cell migration, cell motility^\[[@b34]-[@b35]\]^. These results suggest that these differentially expressed mRNAs play an important role in the tumorigenesis and development of OSCC. The results have provided an experimental basis for further research of these differentially expressed mRNAs in OSCC.

As shown in [***Table 6***](#t06){ref-type="table"}, the differentially expressed genes (DEGs) were enriched in 215 pathways, of which 68 were found to be significantly enriched by KEGG pathway enrichment analysis. These included ECM-receptor pathway interaction and focal adhesion pathways, which have both been previously reported in OSCC^\[[@b29]-[@b31]\]^. In addition, the results of our study support previous studies which reported that mTOR affects the progression of OSCC, suggesting that the mTOR signaling pathway may play a role in OSCC development^\[[@b36]-[@b37]\]^.

To our knowledge, our study presents the first genome-wide profiling of mRNAs of OSCC by high-throughput RNA-Seq. We utilized this data to identify the mRNAs that were significantly up-regulated or down-regulated in OSCC tissue compared to matched paraneoplastic normal tissue. By exploring their GO ontologies, our findings suggest that these differentially expressed mRNAs may act as oncogenes or tumor suppressors in the development and progression of OSCC. Our data has provided novel insights into cancer biology. However, further studies are required to determine their potential roles as diagnostic biomarkers of candidate therapeutic targets for OSCC.
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